| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Opium Tincture |
| Brand | Dropizol® |
| Indication | For severe diarrhoea such as diarrhoea caused by cytostatic medication, radiation or neuroendocrine tumours when use of other anti-diarrhoea treatments have not given sufficient effect. |
| Assessment Process | |
| Rapid review commissioned | 04/03/2019 |
| Rapid review completed | 03/04/2019 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that opium tincture (Dropizol) not be considered for reimbursement at the submitted price*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.